Portal de investigación
Estudio retrospectivo para valorar el impacto del tercer fármaco antirretroviral en la reconstitución inmune de pacientes VIH-naïve.
Datos básicos
- Código:
- RECOFAR
- Protocolo:
- RECOFAR
- EUDRACT:
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Dotación:
- Año de incio:
- 2021
- Año de finalización:
- 2021
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes.
Santos JR; (...); Paredes R
Article. 10.1093/ofid/ofad542. 2023
Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial.
Tenorio CH; (...); Vallecillos CG
Article. 10.1016/j.ijantimicag.2024.107164. 2024
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57).
Podzamczer D; (...); Moreno S
Article. 10.1093/ofid/ofab595. 2022
Differences in epidemiology and mortality between men and women with HIV infection in the CoRIS cohort from 2004 to 2014.
Muñoz Hornero C; (...); Pérez-Elías MJ
Article. 10.1016/j.eimce.2021.07.003. 2021
DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks).
Hidalgo-Tenorio, Carmen; (...); Garcia-Vallecillos, Coral
Article. 10.3390/v14030524. 2022
Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study.
Troya, Jesus; (...); Buzon, Luis
Article. 10.1097/MD.0000000000029252. 2022
Early Detection of Cancer and Precancerous Lesions in Persons with HIV through a Comprehensive Cancer Screening Protocol.
Gutierrez, Felix; (...); Masia, Mar
Article. 10.1093/cid/ciae359. 2024
Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters
Corona, Diana; (...); Rivero, Antonio
Article. 10.1016/j.ijantimicag.2023.107016. 2024
Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study.
Santos JR; (...); Paredes R
Article. 10.3389/fcimb.2023.1187999. 2023
Effectiveness and tolerability of dolutegravir and abacavir/lamivudine administered as two separate pills compared to their equivalent single-tablet regimen in treatment-naive and treatment-experienced patients
Suarez-Garcia, I.; (...); Jarrin, I.
Meeting Abstract. 2021
Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119.
Palacios, R.; (...); Santos, J.
Article. 10.1111/hiv.13489. 2023
eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort
Teira, R; (...); Espinosa, N
Article. 10.1080/25787489.2021.1955197. 2021
Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019.
Fanciulli C; (...); González Garcia J
Article. 10.1111/hiv.13229. 2022
Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.
Ruiz-Rodriguez P; (...); Coscolla M
Article. 10.1128/mBio.02315-21. 2021
Factors associated with late presentation for HIV care in adolescents in Spain
Epalza, Cristina; (...); Luisa Navarro, Maria
Article. 10.1111/hiv.13407. 2022
HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018
Perez-Latorre, L; (...); Gonzalez-Garcia, J
Article. 10.2807/1560-7917.ES.2021.26.25.2000236. 2021
Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection.
Masiá M; (...); Martínez E
Article. 10.1186/s13063-021-05777-6. 2021
Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection (vol 22, 851, 2021)
Masia, M.; (...); Martinez, E.
Correction. 10.1186/s13063-023-07655-9. 2023
Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir+Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b SOLAR Study.
Mussini, Cristina; (...); van Wyk, Jean
Article. 10.1007/s10461-024-04490-0. 2024
IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.
Álvarez H; (...); Poveda E
Article. 10.3389/fimmu.2023.1257725. 2023
Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain
Serrano-Villar, Sergio; (...); de Isla, Leopoldo Perez
Article. 10.1016/j.eimc.2023.07.005. 2024
Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain.
Serrano-Villar, Sergio; (...); Perez de Isla, Leopoldo
Article. 10.1016/j.eimce.2023.07.009. 2023
Laboral Cranio-Facial Cellulitis with Perichondritis and External Otitis, A Case Report
Moreno, Eloy Sempere, Barcelo, Santos Ibanez, Alonso, Marta Montero
Editorial Material. 10.1016/j.eimc.2024.02.008. 2024
Laboral cranio-facial cellulitis with perichondritis and external otitis, a case report.
Sempere Moreno, Eloy, Ibanez Barcelo, Santos, Montero Alonso, Marta
Case Reports. 10.1016/j.eimce.2024.04.004. 2024
Long or complicated mpox in patients with uncontrolled HIV infection.
Corma-Gómez A; (...); Macías J
Article. 10.1002/jmv.29511. 2024
Long term follow-up in HCV infected patients with end stage chronic kidney disease after DAA therapy
Martinez-Camprecios, J; (...); Buti, M
Meeting Abstract. 2021
Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy.
Tarancon-Diez, Laura; (...); Muñoz-Fernández MÁ
Article. 10.1016/j.biopha.2023.114587. 2023
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy
Martinez-Camprecios, Joan; (...); Buti, Maria
Article. 10.1016/j.gastrohep.2022.12.004. 2023
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV( vol 106, pg 136, 2024)
Pelchen-Matthews, Annegret; (...); Wyatt, Christina M.
Correction. 10.1016/j.kint.2024.10.002. 2024
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV.
Pelchen-Matthews, Annegret; (...); Wyatt, Christina M.
Article. 10.1016/j.kint.2024.04.010. 2024
Monocyte Activation and Ageing Biomarkers in the Development of Cardiovascular Ischaemic Events or Diabetes in People with HIV.
Bernardino, Jose I.; (...); Rodes, Berta
Article. 10.3390/microorganisms11071818. 2023
Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis
Article. 10.1097/MD.0000000000032208. 2022
Prevalence of people living with multidrug-resistant HIV and limited treatment options in Spain.
Llibre, Josep M; (...); Alcantara, Felipe Rodriguez
Article. 10.1111/hiv.13650. 2024
Prospective study for the early detection of lung carcinoma in patients with HIV infection (GESIDA study 8815).
Valencia ME; (...); González J
Article. 10.1016/j.eimce.2024.05.005. 2024
Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort
Teira, Ramon; (...); Curran, Adria
Article. 10.1007/s40121-022-00630-y. 2022
Switching to bictegravir/ emtricitabine/tenofovir alafenamide plus darunavir/cobicistat in heavily antiretroviralexperienced, virologically suppressed HIV-infected adults receiving complex regimens: 48-week analysis
Podzamczer, D.; (...); Rivero, A.
Meeting Abstract. 2023
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.
Podzamczer, Daniel; (...); Rivero, Antonio
Article. 10.1093/jac/dkad285. 2023
Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021.
Vinuela, Laura; (...); Garcia, Federico
Article. 10.1002/jmv.29287. 2023
Unplanned pregnancies and social and partner support during pregnancy in Spanish women living with HIV.
Ruiz-Alguero, Marta; (...); Jarrin, Inma
Article. 10.1111/hiv.13469. 2023